A multiproduct cGMP facility focusing on clinical production of biotherapeutics, bioreagents and biomaterials. Assets include 1,000L and 2,000L single-use bioreactors and associated downstream capabilities.
1978 W Winton Ave Hayward, CA 94545 United States of America
Site acquired by Lonza (previously Baxalta).
A hub for biotechnology education and discovery (UCB, Stanford, UCSF).
Downstream process capabilities focused on Clinical manufacturing
Single use chromatography and ultrafiltration/diafiltration systems
Viral inactivation and viral reduction
Buffer production and product collection in single use technologies.
Aseptic bulk drug substance filling into bags and bottles for frozen and refrigerated storage
A fully single use facility focus is on technology transfer of new products
Raw material, in-process, release testing qualification and execution
250L Pilot USP and DSP batch capabilities aligned with large - GMP processing
Stability testing program with analytical support
We operate global quality management systems which comply with national and international standards and regulation.
A recognized, reliable and sustainable partner
We continually strive to reduce our impact on natural systems and the environment, conserve energy and resources, assure safety, health and wellbeing of our employees and help to improve the quality of life in the communities in which we operate.